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PONV Prophylaxis Failure Disproportionately Affects Female Patients, Despite
Intraoperative Computerized Decision Support Guidance
Abstract
Objectives: To compare postoperative nausea and vomiting (PONV) prophylaxis treatment and outcomes
based on patients’ sex, using a retrospective cohort. The setting was the operating room and postanesthesia care unit of a tertiary care university medical center.
Patients: A total of 678 adult male and female patients with American Society of Anesthesiologist (ASA)
scores of 1-4 underwent surgery with general anesthesia. All patients received preoperative PONV risk
assessment. PONV prophylaxis was administered at the discretion of the anesthesia care team members
with guidance from a computerized decision support system.
Measurements: Adequacy of prophylaxis was retrospectively determined based on individual patient risk
factors and the observed treatment received, compared with guideline-based prophylaxis
recommendations. Patient outcome was measured by diagnosis of PONV in recovery.
Results: Comparing patients who received fewer than the guideline-recommended number of prophylactic
antiemetics by sex, 94.6% were female and 5.4% were males (p < 0.001). Patients who received fewer
than guideline-recommended number of antiemetics had significantly higher rates of nausea or vomiting
in the post-anesthesia care unit (30.4% vs 17.5%, p < 0.001).
Conclusion: This retrospective cohort study shows that female patients receiving general anesthesia are
disproportionately affected by failure to adhere to PONV prevention guidelines.
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Abstract
Objectives: To compare postoperative nausea
and vomiting (PONV) prophylaxis treatment
and outcomes based on patients’ sex, using
a retrospective cohort. The setting was the
operating room and post-anesthesia care unit
of a tertiary care university medical center.
Patients: A total of 678 adult male and
female patients with American Society
of Anesthesiologist (ASA) scores of 1-4
underwent surgery with general anesthesia.
All patients received preoperative PONV
risk assessment. PONV prophylaxis
was administered at the discretion of the
anesthesia care team members with guidance
from a computerized decision support system.
Measurements: Adequacy of prophylaxis
was retrospectively determined based
on individual patient risk factors and the
observed treatment received, compared
with guideline-based prophylaxis
recommendations. Patient outcome was
measured by diagnosis of PONV in recovery.
Results: Comparing patients who received
fewer than the guideline-recommended
number of prophylactic antiemetics by sex,
94.6% were female and 5.4% were males
(p < 0.001). Patients who received fewer
than guideline-recommended number of
       
nausea or vomiting in the post-anesthesia care
unit (30.4% vs 17.5%, p < 0.001).
Conclusion: This retrospective cohort study
shows that female patients receiving general
anesthesia are disproportionately affected
by failure to adhere to PONV prevention
guidelines.

Introduction
Postoperative nausea and vomiting (PONV)
is a common complication associated with
general anesthesia. Incidence of PONV is
approximately 30% in the general population
and up to 80% in high-risk individuals.1,2
Postoperative vomiting increases risk of
aspiration, pneumothorax, esophageal rupture
and wound dehiscence.3,4 PONV may also
lead to prolonged time in post-anesthesia
care units (PACU), as well as unplanned
admissions following ambulatory surgery.5,6,7
From a patient satisfaction point of view,
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nausea and vomiting are reported as among
the least desired outcomes following surgery.8
Risk scores:Koivuranta et al. created an
original PONV risk assessment instrument
           
female sex.2 Apfel et al. introduced a
         
to better predict a patients’ risk of PONV:1
history of prior PONV or motion sickness,
female sex, nonsmoker status, and anticipated
postoperative opioid administration. In
pediatrics, the Postoperative vomiting in
Children (POVOC) score is most commonly
used and does not take into consideration
the sex of the patient, as sex does not change
PONV risk in prepubescent children.9
Female Sex as a Risk Factor: Female sex
is the strongest clinical predictor of PONV,
and female patients are 2-3 times more likely
to experience PONV compared to males.10
      
effects from pharmacological prophylaxis.11
The exact mechanisms responsible for the
increased incidence of PONV in females are
unknown. Studies have suggested that PONV
        
phase, with the highest risk occurring during
the follicular phase and lowest risk during
the luteal phase.12,13,14 However, these results
are inconsistent, with poor reproducibility
between studies, casting uncertainty
         
predisposition towards nausea and vomiting.15
Utilization of CDSS: Despite the creation of a
         
on PONV prevention and treatment,
pharmacologic prophylaxis rates are reported
to be as low as 37% in moderate and high
risk patients.1,16,17 To improve guideline
adherence among clinicians, information
technology solutions have been proposed,
including electronic clinical decision support
systems (CDSS). CDSS are automated tools
         
electronic medical record (EMR) to provide
timely reminders and suggested treatments
during episodes of care. At our institution,
a CDSS is used to automatically calculate
surgical patients’ Apfel risk score and prompt
the anesthesia provider to administer PONV
prophylaxis. Previous studies have reported
that implementation of CDSS for PONV
prevention has increased guideline adherence
and lowered PONV incidence.18,19 Other

successful CDSS integrations reported in
anesthesia literature include intraoperative
glucose monitoring, intraoperative blood
pressure control and antibiotic administration
less than 60 minutes prior to skin incision.20,21
Academic Practice: While decision support
tools can provide evidence-based prompts
and treatment suggestions, patient care is
ultimately under the control and clinical
judgement of individual providers. In
academic practices, the anesthesia care team
is comprised of a variety of clinicians (e.g.,
physician anesthesiologists, nurse anesthetists
and anesthesiology residents). This diversity
of individuals, with different experience and
training, can result in markedly different
clinical care decisions. With respect to the
management of PONV, personal preference
and individual viewpoints of the clinician
can affect adherence with published
recommendations and guidelines. Despite
published consensus recommendations and
implementation of CDSS, we hypothesize that
female patients are not receiving the same
level of prophylaxis as males.

Methods
This retrospective study was approved by
the University of Nebraska Medical Center
(UNMC) Institutional Review Board (IRB).
Informed consent for this retrospective study
of existing EMR data was waived by the
UNMC IRB. Records were obtained from
consecutive, elective surgical procedures
performed under general anesthesia on adult
patients between January 2, 2017 and March
31, 2017. Patients with incomplete or missing
clinical data were excluded from analysis.
UNMC is a tertiary-care teaching hospital that
utilizes an anesthesia care team model. Care
teams are led by physician anesthesiologists
          
registered nurse anesthetists (CRNA) or
anesthesiology residents. Preoperative
screening, anesthetic technique planning,
intraoperative management and postanesthesia care were at the discretion of the
care team anesthesiologists, CRNAs and
anesthesiology residents.
Preoperative and post-anesthesia data were
prospectively entered into the electronic
medical record EPIC Systems software
(Epic, Verona, WI) as a routine part of patient
care. Intraoperative data were collected with
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EPIC Anesthesia Information Management
System (AIMS) in all facilities and operating
rooms. Each patient received a preoperative
assessment of their PONV risk within the
EPIC EMR. The PONV assessment questions
were retrospectively used to determine the
prophylaxis level for each patient in the study.
Prophylaxis levels were determined using the
2014 consensus guidelines for PONV and
are based on patients’ Apfel risk score.16 The
following intraoperative prophylaxis treatment
categories were then constructed (Table 1).
Intraoperative decision support was used to
remind the anesthesia care team members
of the patients’ risk and indication of PONV
prophylaxis. The clinical decision support
system utilized the data points acquired during
the preoperative PONV risk assessment to
determine if a patient was at risk. Our CDSS
       
suggests intraoperative administration of
antiemetics for PONV prophylaxis.
For the purposes of this study, an episode of
!"#       
in the post-anesthesia care unit (PACU)
requiring the administration of a rescue
antiemetic medication. Antiemetics available
to be used for either prophylaxis or rescue
included ondansetron, diphenhydramine,
lorazepam, prochlorperazine, promethazine,
scopolamine, haloperidol, metoclopramide
and dexamethasone. Choice of agent was
at the discretion of the treating care team
members.
Data retrieved from EPIC were analyzed
using R statistical computing environment (R
Core Team, 2019). Results are presented as
number (percent) or mean (standard deviation)
where appropriate. Chi-squared tests were
used to compare categorical variables.
P-values less than 0.05 were deemed
   $

Results
A total of 747 adult patients were eligible for
inclusion in the retrospective cohort. Of those,
69 patients were excluded for incomplete
    &    
cohort size of 678 participants. Clinical
demographics and PONV risk factors are
presented in Table 2.
Treatment and Outcomes: The total
incidence of PONV for all patients in the
cohort was 21.1%. Prophylaxis rates varied
       & 
93.2% of the low risk group receiving
more pharmacologic prophylaxis than
recommended by guidelines. Conversely,
85.7% of patients in the high risk group
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Table 1.
PONV risk category based on number of risk factors and intraoperative antiemetics.
PONV Risk Category
Intraoperative
Antiemetics
Administered

Low
(0 Risk Factors)

Moderate
(1 or 2 Risk Factors)

High
(3+ Risk Factors)

None

Adequate

Under

Under

1 or 2

Over

Adequate

Under

3+

Over

Over

Adequate

received fewer agents than consensus
guidelines suggest (p < 0.001). Patients
in the moderate risk group received the
guideline-recommended number of antiemetic
prophylaxis medications in 87.3% of cases
(Table 3).
'& !"#    
across prophylaxis categories. Among patients
who were considered inadequate prophylaxis,
30.4% required treatment for PONV while
in the recovery area (Table 4). In contrast,
patients who received adequate prophylaxis or
excessive prophylaxis were treated for PONV
in 17.5% and 13.5% of cases, respectively (p
< 0.001).
Treatment and Outcomes Based on Sex:
    
different PONV prophylaxis regimens and
 !"#    
than male patients (Table 5). Female patients
       
higher rates than male patients (58.4% vs.
4.5%, respectively, p < 0.001). Of patients
receiving fewer prophylaxis medications than
guidelines recommend, 94.6% were female
(Table 6 and Figure 1). Female patients also
required symptomatic treatment for PONV
 *+$/;    &      
than the 11.8% observed among male patients
(p < 0.001). Of note, baseline PONV risk
      
female patients. Females had a higher rate
of prior PONV or motion sickness history,
21.6%, compared to 4.5% among male
patients (P<0.001). Female patients also
   
 
more frequently than did male patients (73.5%
vs. 64.4%, respectively, p = 0.01). There was
      
between female and male patients. Recovery
times in PACU were similar between males
and females.

Discussion
In this retrospective cohort study, we
report that PONV prophylaxis failure
disproportionately affects female patients
undergoing surgery requiring general

Table 2.
Clinical demographics and PONV risk factors.




Age
Mean (SD)

54.47 (16.25)

BMI
Mean (SD)

31.17 (8.51)

ASA
1

51 (7.5%)

2

218 (32.2%)

3

373 (55.0%)

4

36 (5.3%)

Sex
Female

389 (57.4%)

Male

289 (42.6%)

Smoking Status
Current Smoker

119 (17.6%)

Nonsmoker

559 (82.4%)

Postoperative Opioids
No

206 (30.4%)

Yes

472 (69.6%)

History of PONV
No

581 (85.7%)

Yes

97 (14.3%)

Apfel Risk Score
0

20 (2.9%)

1

127 (18.7%)

2

259 (38.2%)

3

217 (32.0%)

4

55 (8.1%)

Risk Category
Low (Apfel 0-1)

147 (21.7%)

Moderate (Apfel 2)

259 (38.2%)

High (Apfel 3-4)

272 (40.1%)

anesthesia. As a group, the majority of
female patients, 58.4%, were administered
fewer than the guideline-recommended
number antiemetics to prevent PONV. In
contrast, only 4.5% of male patients received
fewer than the recommended number of
prophylactic antiemetics. Female patients
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the under-prophylaxed group, making up
94.6% of the patient total. In addition, the
corresponding rates of nausea or vomiting
requiring treatment among female patients
was more than twice that observed among
male patients (28.0% vs. 11.8%). The overall
observed rate of PONV within the cohort was
21.1%, slightly lower than that reported in the
general population.16,22
Female patients’ predisposition towards
PONV has been well established, as female
sex is the strongest reported risk factor for
the development of postoperative nausea and
vomiting.10 In this cohort, female patients
also had higher rates of two other PONV
risk factors, namely prior history of PONV/
motion sickness and postoperative opioid
administration. Our study also highlights
inconsistent PONV prophylaxis guideline
    & 
in the high-risk patients, who were under
prophylaxis in 87.5% of cases. This failure
to adhere to PONV prevention guidelines
is particularly surprising given the presence
  ?@''  
designed to address PONV risk factors during
intraoperative patient care.
Investigating the effectiveness of CDSS
for PONV prophylaxis compliance was
outside the scope of this study. A report by
Kooij et al., however, described increased
adherence to PONV guidelines following
?@'' &   
risk patients.18 In their study, CDSS was
limited to the preoperative screening clinic
and was not in the setting of the operating
room environment. Gabel et al. extended the
use of clinical decision support technology by
incorporating preoperative decision support,
intraoperative checklists and personalized
email reports to achieve of reduction in PONV
incidence.23 Our investigation suggests that an
 ?@''     
to affect improvements in adherence with
PONV consensus guidelines.
Our study has several limitations. The clinical
data gathered to calculate risk scores were
dependent on the accuracy of preoperative
assessments. Information bias, in which
patients selectively or inconsistently recall
details, could cause patients to inadvertently
misrepresent their actual PONV risk.
Inaccurate PONV risk assessments affect not
only individual clinician’s treatment decisions
but also the CDSS results and prompts.
Because this was an observational study, not
an interventional trial, there was no required
        
to the calculated Apfel PONV risk score
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Table 3.
Prophylaxis administration by risk category.
Low
(N=147)

Moderate
(N=259)

High
(N=272)

p value

Risk Category

< 0.001

Under prophylaxis
Adequate prophylaxis
Over prophylaxis

0 (0%)

7 (2.7%)

233 (85.7%)

10 (6.8%)

226 (87.3%)

39 (14.3%)

137 (93.2%)

26 (10.0%)

0 (0%)

Table 4.
Rates of PONV by prophylaxis category.
Under Prophylaxis
(N=240)

Adequate Prophylaxis
(N=275)

Over Prophylaxis
(N=163)

p value

PONV in Recovery

< 0.001

No PONV

167 (69.6%)

227 (82.5%)

141 (86.5%)

PONV

73 (30.4%)

48 (17.5%)

22 (13.5%)


Comparison of risk factors, PONV prophylaxis rates and PONV rates by sex.
Female
(N=389)

Male
N=289)

p value

Smoking Status



Current Smoker

65 (16.7%)

54 (18.7%)

324 (83.3%)

235 (81.3%)

No

103 (26.5%)

103 (35.6%)

Yes

286 (73.5%)

186 (64.4%)

No

305 (78.4%)

276 (95.5%)

Yes

84 (21.6%)

13 (4.5%)

Under prophylaxis

227 (58.4%)

13 (4.5%)

Adequate prophylaxis

132 (33.9%)

143 (49.5%)

30 (7.7%)

133 (46.0%)

No PONV

280 (72.0%)

255 (88.2%)

PONV

109 (28.0%)

34 (11.8%)

Nonsmoker
Postoperative Opioids

0.010

History of PONV

< 0.001

Level of prophylaxis

< 0.001

Over prophylaxis
PONV in recovery

< 0.001

 
Rates of PONV by prophylaxis category.
Under Prophylaxis
(N=240)

Adequate Prophylaxis
(N=275)

Over Prophylaxis
(N=163)

Sex
Female
Male

p value
< 0.001

227 (94.6%)

132 (48.0%)

30 (18.4%)

13 (5.4%)

143 (52.0%)

133 (81.6%)
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Prophylaxis Categories by Sex

Proportion of Patients

1.00

0.75

0.50

0.25

0.00
Under Prophylaxis

Adequate Prophylaxis
Male

Over Prophylaxis

Female

Figure 1. Proportion of patients based on sex for under, adequate and over prophylaxis (p < 0.001).

or mandatory reaction to the prompts and
reminders provided by the CDSS.
We report that female patients are
disproportionately affected by failure to
adhere to PONV prevention and treatment
guidelines. Furthermore, this disparity was
particularly glaring in an environment where
CDSS technology was employed to identify
patients with multiple PONV risk factors for
immediate treatment by an anesthesia care
team. Future investigations will be needed
to elucidate underlying causes for deviation
from PONV prophylaxis guidelines by
individual practitioners and for the systematic
undertreatment of PONV in female patients. 
https://doi.org/10.32873/unmc.dc.gmerj.2.1.091
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